4
Changes in Ownership
X4 Pharmaceuticals, Inc Filed Acc 0001628280-23-023445
Chief Operating Officer sold 857 shares at $1.93 ($1,654)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| DiBiase Mary Chief Operating Officer | 2023-06-23 | Sale | −857 | $1.93 | $1,654 | 151,000 | D |
| Open-market sales · 857 sh · avg $1.93 · $1,654 | |||||||
Loading xslF345X04/wk-form4_1687810523.xml…